Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Forooghizade, Mohsen"'
Autor:
Gholami, Fatemeh, Hamidi Farahani, Ramin, Karimi Rahjerdi, Ahmad, Ahi, Mohammadreza, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Ansarifar, Akram, Basiri, Pouria, Moradi, Milad, Jahangiri, Arash, Naderi, Kosar, Ghasemi, Soheil, Khatami, Pezhman, Honari, Mohsen, Khodaverdloo, Samane, Shooshtari, Mohammad, Mehr Azin, Hajar, Moradi, Sohrab, Shafaghi, Batool, Allahyari, Hossein, Monazah, Arina, Khodaei Poor, Ali, Taghva, Zahra, Bakhshande, Hooman, Karimi Nia, Mohammad, Solaymani Dodaran, Masoud, Forooghizade, Mohsen
Additional file 1. Inclusion and Exclusion (Eligibility) criteria (pages:2-5). Safety Reporting Guidelines (pages:6-9). Diagram of participants' scheduled visits (page 11). COVID-19 case definitions (pages:12-13). Scoring the severity of local advers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d9d02cc0f5b7508428f116aaef0df9
Autor:
Gholami F; Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.; Clinical Trial Center of Iran University of Medical Sciences, Tehran, Iran., Hamidi Farahani R; AJA University of Medical Sciences, Tehran, Iran., Karimi Rahjerdi A; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran.; Stem Cell Technology Research Center (STRC), Tehran, Iran., Ahi M; Clinical Trial Center of Iran University of Medical Sciences, Tehran, Iran., Sheidaei A; Clinical Trial Center of Iran University of Medical Sciences, Tehran, Iran., Gohari K; Clinical Trial Center of Iran University of Medical Sciences, Tehran, Iran., Rahimi Z; Clinical Trial Center of Iran University of Medical Sciences, Tehran, Iran., Ansarifar A; Clinical Trial Center of Iran University of Medical Sciences, Tehran, Iran., Basiri P; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Moradi M; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Jahangiri A; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Naderi K; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran.; Stem Cell Technology Research Center (STRC), Tehran, Iran., Ghasemi S; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Khatami P; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Honari M; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Khodaverdloo S; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Shooshtari M; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Mehr Azin H; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Moradi S; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Shafaghi B; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Allahyari H; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Monazah A; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Khodaei Poor A; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Taghva Z; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Bakhshande H; Clinical Trial Center of Iran University of Medical Sciences, Tehran, Iran., Karimi Nia M; Milad Daro Noor Pharmaceutical (MDNP) Company IR, Tehran, Iran., Solaymani Dodaran M; Clinical Trial Center of Iran University of Medical Sciences, Tehran, Iran., Forooghizade M; Malek Ashtar University of Technology, Tehran, Iran. fakhravacrct@gmail.com.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2023 Feb 24; Vol. 23 (1), pp. 118. Date of Electronic Publication: 2023 Feb 24.
